Kevin Warner, Ph.D.
Vice President, Pharmaceutical Development
Dr. Kevin Warner joined Alucent Biomedical from Allergan, Inc. where he held roles of increasing responsibility in product development, including serving most recently as the director of small molecule development where he lead formulation development activities in support of clinical studies and commercialization. Prior to that role, Dr. Warner held scientific and research positions at ZARS Pharma where he conducted research to develop novel dermal and transdermal formulations. Dr. Warner holds six U.S. Patents and has a doctorate in pharmaceutics and pharmaceutical chemistry from the University of Utah. He earned a Bachelor of Science in chemistry from Brigham Young University.